Recruitment and reach in a pragmatic behavioral weight loss randomized controlled trial: implications for real-world primary care practice

Table 4 Medical co-morbidities and healthcare utilization of participants versus non-participants who were patients at a subset of clinics^b

	Enrolled participants (n = 402; 10 clinics)	Non-participants (n = 6199; 10 clinics)
Comorbid conditions
Type 2 Diabetes	16.9% (7.6%)	14.1% (4.2)	0.14
Cardiovascular disease	2.5% (2.4)	5.0% (2.2)	0.03
Cancer	21.2% (7.2)	17.0% (3.5)	0.11
Chronic kidney disease	7.5% (3.5)	7.9% (2.7)	0.71
Chronic pulmonary disease	13.7% (4.8)	14.4% (1.8)	0.65
Joint replacement history	10.9% (4.4)	8.1% (2.7)	0.02
Depression	7.0% (4.9)	7.4% (3.1)	0.84
Current smoker	5.9% (4.1)	16.9% (5.3)	< 0.001
Former Smoker	29.2% (7.6)	27.8% (7.1)	0.58
Ambulatory visits in past 3 years	13.9 (2.6)	13.0 (1.0)	0.32
Inpatient days in past 3 years	0.41 (0.245)	.98 (0.37)	0.001

Data are reported as means at the clinic level
^bThe subset of clinics includes 10 sites within the Marshfield Clinic healthcare system

ISSN: 2731-4553